XML 61 R50.htm IDEA: XBRL DOCUMENT v3.19.1
Acquisitions - Purchase price as of the Regentys acquisition (Details) - USD ($)
Jan. 31, 2019
Jan. 07, 2019
Nov. 27, 2018
Nov. 02, 2018
Oct. 03, 2018
Jul. 31, 2018
Jan. 31, 2018
Dec. 28, 2017
Jul. 31, 2017
Jan. 18, 2017
Cash and cash equivalents $ 2,373,821         $ 1,046,365 $ 2,048,067   $ 2,879,165  
Other current assets 286,439         96,251        
Property and equipment, net 645,607         31,536        
Accounts payable and accrued liabilities (16,863,991)         (11,044,774)        
Notes payable (40,968,321)         (320,000)        
Net Tangible Assets (73,069,456)         (6,606,854)        
Non-controlling interest 21,683,698         $ (5,576,272)        
Goodwill               $ 0   $ 13,400,000
Total                    
Cash and cash equivalents 2,410,150                  
Property and equipment, net 652,590                  
Notes payable (3,403,948)                  
Notes receivable 1,387,763                  
Total Fair Value of Assets Acquired 9,822,070                  
Total Purchase Price 35,000,000                  
Goodwill 25,177,930                  
Final Allocation                    
Goodwill $ 0                  
Regentys                    
Cash and cash equivalents   $ 61,857                
Other current assets   13,138                
Property and equipment, net   444                
Accounts payable and accrued liabilities   (1,181,920)                
Notes payable   (639,009)                
Loans from related parties   (16,506)                
Net Tangible Assets   (1,761,996)                
Notes receivable   14,345,205                
In-process research & development   3,510,680                
Deferred tax liability   (889,782)                
Redeemable non-controlling interest   (4,073,898)                
Non-controlling interest   (9,870,762)                
Total Fair Value of Assets Acquired   1,259,447                
Cash paid prior to the time of closing   400,000                
Note receivable from Generex   14,345,205                
Total Purchase Price   14,745,205                
Goodwill   $ 13,485,758                
Olaregen                    
Cash and cash equivalents     $ 608,419              
Other current assets     37,950              
Net Tangible Assets     (641,994)              
Notes receivable     11,472,663              
In-process research & development     3,980,000              
Deferred tax liability     (1,040,173)              
Redeemable non-controlling interest     0              
Non-controlling interest     (11,999,559)              
Cash paid prior to the time of closing     400,000              
Note receivable from Generex     11,472,663              
Goodwill     $ 8,027,738              
"Veneto Second Closing"                    
Cash and cash equivalents                  
Property and equipment, net                  
Notes payable       (3,403,948)            
Notes receivable                  
Total Fair Value of Assets Acquired       3,706,052            
Total Purchase Price       20,000,000            
Goodwill       $ 16,293,948            
"Veneto First Closing"                    
Cash and cash equivalents         $ 2,410,150          
Property and equipment, net         652,590          
Notes payable                  
Notes receivable         1,387,763          
Total Fair Value of Assets Acquired         6,116,018          
Total Purchase Price         15,000,000          
Goodwill         $ 8,883,982